AAAAAA

   
Results: 1-14 |
Results: 14
EFFICACY AND 6-MONTH SAFETY OF SIMVASTATIN 80 MG DAY - RESULTS FROM THE WORLDWIDE SIMVASTATIN EXPANDED DOSE PROGRAM (WSEDP)/
Authors: OSE L KASTELEIN JJP SCOTT R STEIN EA CAMPODONICO S ESCOBAR ID TATE AC CORSETTI L SHAHANE A MITCHEL YB MERCURI M
Citation: L. Ose et al., EFFICACY AND 6-MONTH SAFETY OF SIMVASTATIN 80 MG DAY - RESULTS FROM THE WORLDWIDE SIMVASTATIN EXPANDED DOSE PROGRAM (WSEDP)/, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 8(3), 1998, pp. 135-143
EFFICACY AND SAFETY OF SIMVASTATIN 80 MG DAY IN HYPERCHOLESTEROLEMIC PATIENTS/
Authors: STEIN EA DAVIDSON MH DOBS AS SCHROTT H DUJOVNE CA BAYS H WEISS SR MELINO MR STEPANAVAGE ME MITCHEL YB
Citation: Ea. Stein et al., EFFICACY AND SAFETY OF SIMVASTATIN 80 MG DAY IN HYPERCHOLESTEROLEMIC PATIENTS/, The American journal of cardiology, 82(3), 1998, pp. 311-316
EXPANDED DOSES OF SIMVASTATIN - EFFICACY AND SAFETY OF 80 AND 160 MG IN HYPERCHOLESTEROLEMIA
Authors: WEISS SR KNOPP R DAVIDSON M STEIN EA LASKARZEWSKI P ILLINGWORTH DR DUJOVNE C HUNNINGHAKE D MELINO MR MITCHEL YB
Citation: Sr. Weiss et al., EXPANDED DOSES OF SIMVASTATIN - EFFICACY AND SAFETY OF 80 AND 160 MG IN HYPERCHOLESTEROLEMIA, Journal of the American College of Cardiology, 29(2), 1997, pp. 8064-8064
EXPANDED-DOSE SIMVASTATIN IS EFFECTIVE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Authors: RAAL FJ PILCHER GJ ILLINGWORTH DR PAPPU AS STEIN EA LASKARZEWSKI P MITCHEL YB MELINO MR
Citation: Fj. Raal et al., EXPANDED-DOSE SIMVASTATIN IS EFFECTIVE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, Atherosclerosis, 135(2), 1997, pp. 249-256
EXTENDING THE DOSING RANGE FOR SIMVASTATIN - THE EFFICACY AND SAFETY OF SIMVASTATIN 80 MG D/
Authors: OSE L CORSETTI LA TATE AC SHAHANE A MITCHEL YB
Citation: L. Ose et al., EXTENDING THE DOSING RANGE FOR SIMVASTATIN - THE EFFICACY AND SAFETY OF SIMVASTATIN 80 MG D/, Atherosclerosis, 134(1-2), 1997, pp. 131-131
CHOLESTEROL-LOWERING EFFICACY OF SIMVASTATIN AT DOSES OF 80 AND 160 MG D IN A NEW LOW SYSTEMIC EXPOSURE FORMULATION/
Authors: STEIN EA DAVIDSON MH DUJOVNE CA INSULL W TOTH P MITCHEL YB MELINO MR TOBERT JA
Citation: Ea. Stein et al., CHOLESTEROL-LOWERING EFFICACY OF SIMVASTATIN AT DOSES OF 80 AND 160 MG D IN A NEW LOW SYSTEMIC EXPOSURE FORMULATION/, Atherosclerosis, 130, 1997, pp. 22-22
TREATMENT OF PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH EXPANDED DOSES OF SIMVASTATIN
Authors: RAAL FJ PILCHER GJ PIETERSE AC STEIN EA LASKARZEWSKI P ILLINGWORTH DR MELINO MR MITCHEL YB
Citation: Fj. Raal et al., TREATMENT OF PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH EXPANDED DOSES OF SIMVASTATIN, Atherosclerosis, 130, 1997, pp. 119-119
THE EFFICACY AND 6-WEEK TOLERABILITY OF SIMVASTATIN 80 AND 160 MG DAY/
Authors: DAVIDSON MH STEIN EA DUJOVNE CA HUNNINGHAKE DB WEISS SR KNOPP RH ILLINGWORTH DR MITCHEL YB MELINO MR ZUPKIS RV DOBRINSKA MR AMIN RD TOBERT JA
Citation: Mh. Davidson et al., THE EFFICACY AND 6-WEEK TOLERABILITY OF SIMVASTATIN 80 AND 160 MG DAY/, The American journal of cardiology, 79(1), 1997, pp. 38-42
ASSESSMENT OF CORONARY VASCULAR REACTIVITY AFTER CHOLESTEROL-LOWERING
Authors: YEUNG A HODGSON JM WINNIFORD M VITA J KLEIN L TREASURE C KERN M PLOTKIN D SHIH WC MITCHEL YB CHARBONNEAU F GANZ P
Citation: A. Yeung et al., ASSESSMENT OF CORONARY VASCULAR REACTIVITY AFTER CHOLESTEROL-LOWERING, Circulation, 94(8), 1996, pp. 2338-2338
LONG-TERM EFFICACY AND TOLERABILITY OF SIMVASTATIN IN A LARGE COHORT OF ELDERLY HYPERCHOLESTEROLEMIC PATIENTS
Authors: LANSBERG PJ MITCHEL YB SHAPIRO D KASTELEIN JJP ALTMAN R JERUMS G BOLZANO K GIANNINI S DAVIGNON J DEWAILLY P DARIOLI R MANCINI M SCOTT R HAYDEN MR
Citation: Pj. Lansberg et al., LONG-TERM EFFICACY AND TOLERABILITY OF SIMVASTATIN IN A LARGE COHORT OF ELDERLY HYPERCHOLESTEROLEMIC PATIENTS, Atherosclerosis, 116(2), 1995, pp. 153-162
LACK OF EFFECT OF LOVASTATIN ON RESTENOSIS AFTER CORONARY ANGIOPLASTY
Authors: WEINTRAUB WS BOCCUZZI SJ KLEIN JL KOSINSKI AS KING SB IVANHOE R CEDARHOLM JC STILLABOWER ME TALLEY JD DEMAIO SJ ONEILL WW FRAZIER JE COHENBERNSTEIN CL ROBBINS DC BROWN CL ALEXANDER RW OWEN D SCHUMACHER P MITCHEL YB HIRSCH LJ MELINO MR BEATTIE OP GUDEL D PLOTKIN D TATE A ZUPKIS R SHAPIRO D HALL WD KUTNER M WATTS N SCHLANT R SHEN Y HICKS F CANUP D PERLEE P LE A HOWARD J HOWARD B BROWN WV LI X TREASURE C GATLIN S HURST JW SCHROEDER D HARRISON D DELAFONTAINE P RUNGE M ALAZRAKI N TAYLOR A DOUGLAS JS KIM S THORNTON A HAYNES S WEBSTER J MERLINO J MORRIS DC LIBERMAN HA WEAVER C CURRY C WILLIS W ROSS D BERSIN RM ELLIOT CM HABER RH KOWALCHUK GJ SIMONTON CA WILSON BH ZIMMERN SH PORTER B TUCKER T CRENSHAW M HALL D WALPOLE H GLAZER M THOMPSON J SPITLER E CHURCHWELL A ROSENTHAL RL SCHUMACHER JR GRODIN JM JOHNSTON SB FRANKLIN JO LEONARD BM ROSENBERG FR RAICH A GOLDENBERG EM DOOREY A WEST J HOPKINS JT BLASETTO JW RITTER JM ZOLNICK MR ALFIERI A BOYLE K GRUBBS D DISABATINO A FEEHS S PICORA MJ DONOHUE BC HART N GRANATO J GRILL H STRACCI P FLORES A SCHULMAN D ZAHREN L ORIE JE ONEILL C KENNEDY K MCMARTIN D YUSSMAN Z ETKA W CORWIN J MOONEY M FISHMANMOONEY J KUMMER B KNOPF W LEMBO N SHAFTEL J CAMP C MOYE R
Citation: Ws. Weintraub et al., LACK OF EFFECT OF LOVASTATIN ON RESTENOSIS AFTER CORONARY ANGIOPLASTY, The New England journal of medicine, 331(20), 1994, pp. 1331-1337
COMPARATIVE EFFECTS OF LOVASTATIN AND NIACIN IN PRIMARY HYPERCHOLESTEROLEMIA - A PROSPECTIVE TRIAL
Authors: ILLINGWOUTH DR STEIN EA MITCHEL YB DUJOVNE CA FROST PH KNOPP RH TUN P ZUPKIS RV GREGUSKI RA
Citation: Dr. Illingwouth et al., COMPARATIVE EFFECTS OF LOVASTATIN AND NIACIN IN PRIMARY HYPERCHOLESTEROLEMIA - A PROSPECTIVE TRIAL, Archives of internal medicine, 154(14), 1994, pp. 1586-1595
LOVASTATIN IN PRAVASTATIN COMPARATIVE TRIAL - COST-EFFECTIVENESS - REPLY
Authors: MITCHEL YB NG J MELINO MR
Citation: Yb. Mitchel et al., LOVASTATIN IN PRAVASTATIN COMPARATIVE TRIAL - COST-EFFECTIVENESS - REPLY, The American journal of cardiology, 73(5), 1994, pp. 417-418
EVALUATION OF SUSTAINED CONTROLLED-RELEASE DOSAGE FORMS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A (HMG-COA) REDUCTASE INHIBITORS IN DOGS ANDHUMANS
Authors: CHENG HY SUTTON SC PIPKIN JD ZENTNER GM ROGERS JD SCHWARTZ JI MITCHEL YB GRASING K SCHWARTZ MS AMIN RD LIU L EBEL DL COULTER A ENGLE K MCCLELLAND GA LUI CY RORK GS
Citation: Hy. Cheng et al., EVALUATION OF SUSTAINED CONTROLLED-RELEASE DOSAGE FORMS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A (HMG-COA) REDUCTASE INHIBITORS IN DOGS ANDHUMANS, Pharmaceutical research, 10(11), 1993, pp. 1683-1687
Risultati: 1-14 |